YUTANI SHIGERU 由谷茂

… Alternative Names

由谷茂ユタニシゲル

YUTANI Shigeru 由谷茂

Less

Researcher Number	20279160
Affiliation (Current)	2025: 久留米大学, 付置研究所, 教授
Affiliation (based on the past Project Information) *help	2016: 久留米大学, がんワクチンセンター, 教授 2014 – 2015: 久留米大学, がんワクチンセンター, 准教授 2014 – 2015: 久留米大学, 付置研究所, 准教授 2013: 久留米大学がんワクチンセンター, 付置研究所, 准教授 2006 – 2007: 久留米大学, 医学部, 講師 1997 – 1999: 久留米大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Tumor therapeutics / Gastroenterology Except Principal Investigator Living organism molecular science / Gastroenterology / Tumor diagnostics / Clinical nursing
Keywords	Principal Investigator ELISPOT / Tcell exhaustion / Biliary tract cancer / Cancer vaccine / MDSC / Treg / T cell exhaustion / Immunotherapy / CTL / Billiary tract cancer … More / Cyclophoshamide / PFS / Overall survival / Peptide vaccine / 血清IL-6値 / シクロホスファミド / キラーーT細胞 / 免疫療法 / ペプチドワクチン / 胆道がん / アロキラー / 肝細胞癌 / 細胞障害性Tリンパ球 / HLA拘束性 … More Except Principal Investigator MAGE-4 / immunology / biotechnology / allergy / virus / cancer / 免疫学 / バイオテクノロジー / 癌 / ウィルス / アレルギー・ぜんそく / Prediction of Cancer / Liver cirrhosis / Hepatocellular carcinoma / Tumor rejection antigen / 肝細胞癌 / 肝硬変 / 発癌予知 / 肝癌 / 癌拒絶抗原 / SNPｓ / がん予後予測 / バイオマーカー / 血漿 / がん / SNPs / ペプチドワクチン / サイトカイン / ハプトグロビン / がん患者のQOLとSOC / がん患者への援助 / QOL / SOC / がんペプチドワクチン / 患者支援システムの構築 / 先進医療 Less

Haptoglobin polymorphism as a prognostic biomarker for peptide vaccine efficacy in cancer patients
- Principal Investigator
  
  Shichijo Shigeki
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor diagnostics
- Research Institution
  Kurume University
A randomized phase II trial of personalized peptide vaccine with low dose cyclophoshamide in biliary tract cancerPrincipal Investigator
- Principal Investigator
  
  YUTANI SHIGERU
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Kurume University
Construction of support system for the cancer patients who have advanced medicine
- Principal Investigator
  
  Mayumi TAMURA
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Clinical nursing
- Research Institution
  St. Mary's College
  University of Miyazaki
Study of molecular basis for T cell-mediated recognition of antigens in subjects with HLA-A3 super type
- Principal Investigator
  
  ITOH Kyogo
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Living organism molecular science
- Research Institution
  Kurume University
Detection of MAGE-4 Protein Sera of Patients with Liver Cirrhosis a useful maker for prediction of hepatocellular carcinoma
- Principal Investigator
  
  TANAKA Masatoshi
- Project Period (FY)
  1998 – 1999
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
HLA-A11拘束性肝癌特異的癌退宿抗原遺伝子のクローニングPrincipal Investigator
- Principal Investigator
  
  由谷茂
- Project Period (FY)
  1997 – 1998
- Research Category
  
  Grant-in-Aid for Encouragement of Young Scientists (A)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University

All 2017 2016 2007 2006

All Journal Article Presentation

[Journal Article] A randomized phase Ⅱ trial of personalized peptide vaccine with low dose cyclophoshamide in biliary tract cancer2017
- Author(s)
  白濱貴久、由谷　茂、七條茂樹他
- Journal Title
  
  Cancer Science
  
  Volume: in press
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26430175
[Journal Article] Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer2016
- Author(s)
  Muroya D, Yutani S, Shichijo S, Yamada A, Sakamoto S, Naito M, Okuda K, Morita M, Yamaguchi R, and Itoh K
- Journal Title
  
  Evidence-Based Complementary and Alternative Medicine
  
  Volume: 2016 Issue: 1
- DOI
  10.1155/2016/5929525
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26430148
[Journal Article] Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus(HCV) lb who failed to respond to interferon-based therapy.2007
- Author(s)
  Yutani S, Yamada A, Yoshida K, Takao Y, Tamura M, Komatsu N, Ide T, Tanaka M, Sata M, Itoh K
- Journal Title
  
  Vaccine 25
  
  Pages: 7429-35
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I -A alleles.2007
- Author(s)
  Shichijo S, Komohara Y, Matsueda S, Yutani S, Komatsu N, Sata M, Yamada A, Itoh K
- Journal Title
  
  The 66th Annual Meeting of the Japanese Cancer Association.(Yokohama) 10/3-5
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Serum levels of IgG to the peptide of HCVlb core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.2007
- Author(s)
  Takao Y, Yamada A, Yutani S, Ono T, Nagao Y, Ando E, Ide T, Itoh K, Sata M
- Journal Title
  
  Med Microbiol Immunol. 196
  
  Pages: 157-164
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus(HCV)1b who failed to respond to interferon-based therapy2007
- Author(s)
  Yutani S, Itoh K, et. al.
- Journal Title
  
  Vaccine 25
  
  Pages: 7429-35
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] A new epitope peptide derived from hepatitis C virus lb possessing the capacity to induce cytotoxic T-lymphocytes in HCVlb-infected patients with HLA-A11, -A31 and -A33.2007
- Author(s)
  Matsueda S, Yamada A, Takao Y, Tamura M, Komatsu N, Yutani S, Ide T, Sata M, Itoh K
- Journal Title
  
  Cancer Immunol Immunother. 56
  
  Pages: 1359-66
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Phase I clinical study of a presonalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy2007
- Author(s)
  Yutani S, Itoh K, et. al.
- Journal Title
  
  Vaccine 25
  
  Pages: 7429-7435
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] New epitope peptides derived from hepatitis C virus(HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.2006
- Author(s)
  Wang Y, Takao Y, Harada M, Yutani S, Ide T, Sata M, Itoh K, Yamada A
- Journal Title
  
  Microbiol Immunol 50
  
  Pages: 857-865
- NAID
  10018398215
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Presentation] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I -A alleles.2007
- Author(s)
  Shichijo S, Komohara Y, Matsueda S, Yutani S, Komatsu N, Sata M, Yamada A, Itoh K
- Organizer
  The 66th Annual Meeting of the Japanese Cancer Association.
- Place of Presentation
  Yokohama
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147

1. Shichijo Shigeki (30080592)

# of Collaborated Projects: 4 results

# of Collaborated Products: 4 results
2. YAMADA AKIRA (50158177)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
3. NOGUCHI Masanori (10140691)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. Mayumi TAMURA (00506272)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. SUETSUGU NORIE (60363355)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. TANAKA Masatoshi (60179786)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. ITOH Kyogo (50125499)

# of Collaborated Projects: 1 results

# of Collaborated Products: 8 results
8. SAKAMOTO Kikuo (70279222)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 山田康秀 (80290956)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. 高島淳生 (20576186)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 白濱貴久 (00647787)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

YUTANI SHIGERU 由谷 茂

由谷 茂 ユタニ シゲル

YUTANI Shigeru 由谷 茂

Research Projects

Research Products

Co-Researchers

Haptoglobin polymorphism as a prognostic biomarker for peptide vaccine efficacy in cancer patients

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

A randomized phase II trial of personalized peptide vaccine with low dose cyclophoshamide in biliary tract cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Construction of support system for the cancer patients who have advanced medicine

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Study of molecular basis for T cell-mediated recognition of antigens in subjects with HLA-A3 super type

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Detection of MAGE-4 Protein Sera of Patients with Liver Cirrhosis a useful maker for prediction of hepatocellular carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

HLA-A11拘束性肝癌特異的癌退宿抗原遺伝子のクローニングPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] A randomized phase Ⅱ trial of personalized peptide vaccine with low dose cyclophoshamide in biliary tract cancer2017

Author(s)

Journal Title

Data Source

[Journal Article] Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus(HCV) lb who failed to respond to interferon-based therapy.2007

Author(s)

Journal Title

Description

Data Source

[Journal Article] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I -A alleles.2007

Author(s)

Journal Title

Description

Data Source

[Journal Article] Serum levels of IgG to the peptide of HCVlb core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.2007

Author(s)

Journal Title

Description

Data Source

[Journal Article] Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus(HCV)1b who failed to respond to interferon-based therapy2007

Author(s)

Journal Title

Description

Data Source

[Journal Article] A new epitope peptide derived from hepatitis C virus lb possessing the capacity to induce cytotoxic T-lymphocytes in HCVlb-infected patients with HLA-A11, -A31 and -A33.2007

Author(s)

Journal Title

Description

Data Source

[Journal Article] Phase I clinical study of a presonalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy2007

Author(s)

Journal Title

Data Source

YUTANI SHIGERU 由谷茂

由谷茂ユタニシゲル

YUTANI Shigeru 由谷茂